ORIFARM GENERICS HOLDING A/S

CVR 27347223 · Public limited company (A/S) · Active · Low risk

ORIFARM GENERICS HOLDING A/S is a Public limited company (A/S), founded on , based in Odense S. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 2.4bn and a net result of DKK 273.1m.

Bankruptcy risk for ORIFARM GENERICS HOLDING A/S

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 18% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Reporting classReporting class C, stor virksomhed · bankruptcy rate 1.1%0.13×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Company typeA/S · bankruptcy rate 4.4%0.50×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
27347223
Status
Active
Company type
Public limited company (A/S)
Founded
(23 years)
Address
Energivej 15
5260 Odense S
Municipality
Odense
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 1.3m
Employees
0 (2016)
Auditor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late1 of 23
Missing annual reportNo
Negative equityNo
Equity ratio70.6%
Current ratio27%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address31
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
RevenueDKK 459.5m––
Gross profitDKK 467.9mDKK 243.2mDKK 326.8m
Net profitDKK 273.1mDKK 89.4mDKK 91.8m
EquityDKK 2.4bnDKK 2.1bnDKK 2.2bn
Total assetsDKK 3.4bnDKK 3.4bnDKK 3.5bn
Short-term debtDKK 852.2mDKK 1.2bn–
Avg. employees0––

Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025149
1 Jan 2024 – 31 Dec 2024164
1 Jan 2023 – 31 Dec 2023162
1 Jan 2022 – 31 Dec 2022159
1 Jan 2021 – 31 Dec 2021186 Late
1 Jan 2020 – 31 Dec 2020165
1 Jan 2019 – 31 Dec 2019176
1 Jan 2018 – 31 Dec 2018151
1 Jan 2017 – 31 Dec 2017151
1 Jan 2016 – 31 Dec 2016150
1 Jan 2015 – 31 Dec 2015158
1 Jan 2014 – 31 Dec 2014149
1 Jan 2013 – 31 Dec 2013151
1 Jan 2012 – 31 Dec 2012152
1 Jan 2011 – 31 Dec 2011159
1 Jan 2010 – 31 Dec 2010159
1 Jan 2009 – 31 Dec 2009154
1 Jan 2008 – 31 Dec 2008159
1 Jan 2007 – 31 Dec 2007160
1 Jan 2006 – 31 Dec 2006151

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
BoardHans Carl Bøgh-SørensenCurrent
BoardBirgitte Bøgh-SørensenCurrent
BoardMads Fink EriksenCurrent
BoardNicki Lund KristensenCurrent
BoardOle Michael Friis
BoardJan Johannes Wøidemann
BoardNiels Harald de Coninck-Smith
BoardClaus Christian Bayer
BoardHans Christian Eberhard Groth Teisen
BoardErik Sandberg
BoardPeter Arend William Burema
BoardJean-Francois Loumeau
BoardClaudio Albrecht
BoardClaus Christian Bayer
BoardRolf Eckersberg
Owner (100%)ORIFARM GROUP A/SCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB

Address history (1 moves)

Energivej 15, 5260 Odense S
Energivej 15, 5260 Odense S

Former names

ORIFARM GENERICS HOLDING A/S – now
COPYFARM HOLDING A/S –

Employees per year

Number of employees at ORIFARM GENERICS HOLDING A/S per year112009: 020092011: 020112012: 020122013: 020132014: 020142015: 020152016: 02016

Other companies at the same address

Similar companies in Odense

Questions and answers about ORIFARM GENERICS HOLDING A/S

Has ORIFARM GENERICS HOLDING A/S gone bankrupt?

No, ORIFARM GENERICS HOLDING A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of ORIFARM GENERICS HOLDING A/S?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of ORIFARM GENERICS HOLDING A/S?

ORIFARM GENERICS HOLDING A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was ORIFARM GENERICS HOLDING A/S founded?

ORIFARM GENERICS HOLDING A/S was founded on 12 September 2003.

What is the equity of ORIFARM GENERICS HOLDING A/S?

Equity was DKK 2.4bn according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.